Rafarma Pharmaceuticals Inc. (RAFA): ATTORNEY LETTER WITH RESPECT TO CURRENT...

Home > Boards > US Listed > Biotechs > Rafarma Pharmaceuticals Inc. (RAFA)

Followed By	10
Posts	1521
Boards Moderated	0
Alias Born	11/01/2017

Eurotradr

Friday, April 01, 2022 3:56:28 PM

Re: None

ATTORNEY LETTER WITH RESPECT TO CURRENT INFORMATION –
RAFARMA PHARMACEUTICALS, INC. (RAFA) - http://www.otcmarkets.com/financialReportViewer?symbol=RAFA&id=326438 THE LAW OFFICES OF M. AMBER BARGER, PLLC

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Follow Board

Keyboard Shortcuts

Report TOS Violation

Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock
Disney+, Hulu, and ESPN+ Offer the Best in Streaming Inside The Disney Bundle Pavilion at D23 Expo, Including Special Perks for Disney+ Subscribers
Nvidia, Companies to Collaborate on Evolving 3D Tech Beyond Visual Effects
Jakubowitz Law Reminds Unity Shareholders of a Lead Plaintiff Deadline of September 6, 2022
Digital Media Solutions, Inc. Announces Q2 2022 Financial Results
CARNIVAL CRUISE LINE REMOVES PRE-CRUISE TESTING FOR VACCINATED GUESTS AND WELCOMES ALL UNVACCINATED TO SAIL
ESS Announces Strategic Partnership to Deploy Long-Duration Energy Storage in Australia and Deliver an Expected 12 GWh of Iron Flow Batteries
Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science
Exchange Listing, LLC Advises Treasure Global Inc. and Secures Initial Public Offering and Nasdaq Listing
ADC Therapeutics meldet Finanzergebnisse für das zweite Quartal 2022 und gibt aktuelle Unternehmensentwicklungen bekannt
Smith Micro Reports Second Quarter 2022 Financial Results
Trending: Tesla Shares Gain After Elon Musk Sold Nearly $7 Billion in Stock
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks
ADRs End Higher; Aviva, Alibaba Trade Actively
WeTrade Group Inc. Announces US$50 Million Sales of Monkeypox Virus Test Kits to Parkway Medical Limited
Natura &Co's sales stabilized in Q2 and profitability is impacted by cost pressure
IMAC Holdings, Inc. Announces $3.9 Million Registered Direct and Private Placement
Survey: Cardiovascular Patients on Aspirin Therapy Prefer VAZALORE® 81 mg
New Teacher-Driven Tutoring Enables Educators to “Prescribe” Additional Live Academic Support for Students at All Levels
ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

Detailed Quote